KCa3.1 channel activators (University of California Davis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKCa3.1 channel activators (University of California Davis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonistsVoltage-gated calcium channel agonists
TargetsVoltage-gated calcium channelPotassium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A